Classical complement pathway

Classical Complement Pathway is a component of the immune system that enhances (complements) the ability of antibodies and phagocytic cells to clear pathogens from an organism. It is part of the complement system, which is a complex and highly regulated network of proteins that play a crucial role in innate immunity and also bridge innate and adaptive immunity. The classical pathway is one of three pathways that activate the complement system, the other two being the alternative complement pathway and the lectin pathway.

Activation

The classical complement pathway is initiated when C1-complex (a molecule composed of C1q, C1r, and C1s) binds to Fc regions of antibodies (IgM or IgG) that are themselves bound to antigens on the surface of a pathogen. This interaction induces a conformational change in the C1 complex, activating C1s, which then cleaves and activates C4 and C2 components of the complement system. The cleavage products C4b and C2a together form the C3 convertase (C4b2a), which is a crucial enzyme in the pathway that cleaves C3 into C3a and C3b, propagating the complement activation cascade.

Functions

The primary functions of the classical complement pathway include:

• Opsonization: C3b, a product of C3 cleavage, coats the surface of pathogens, marking them for phagocytosis by phagocytes.
• Inflammation: C3a and other small fragments released during complement activation act as chemotactic agents, attracting immune cells to the site of infection and promoting inflammation.
• Lysis of Pathogens: The terminal components of the complement system (C5-C9) assemble into the membrane attack complex (MAC), which creates pores in the cell membranes of pathogens, leading to their lysis.

Regulation

The activity of the classical complement pathway is tightly regulated to prevent damage to host cells. Regulatory proteins such as C1-inhibitor, which inhibits the C1 complex, and Factor H and Factor I, which prevent the formation of the C3 convertase, play critical roles in controlling the complement cascade.

Clinical Significance

Dysregulation or genetic deficiencies in components of the classical complement pathway can lead to a variety of diseases, including immune complex diseases, such as systemic lupus erythematosus (SLE), and recurrent infections. On the other hand, excessive activation of the complement system can contribute to inflammatory diseases and tissue damage.